Iovance Biotherapeutics Inc - Company Profile
Powered by
All the data and insights you need on Iovance Biotherapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Iovance Biotherapeutics Inc Strategy Report
- Understand Iovance Biotherapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Iovance is a biotechnology company that develops novel cancer immunotherapies. The company's technology platform – tumor infiltrating lymphocytes (TIL), strong collaborations and focus on R&D activities are its strengths, whereas history of losses is cause of concern for the company. However, it can drive growth through growing market for head and neck squamous cell carcinoma, strategic agreements and Orphan and Fast Track Drug designation. However, competitive environment, stringent government regulations and dependence on third parties could adversely affect its future business operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer